GSK’s HIV treatment, ‘Triumeq’ lands in approximately s30 major hospitals
GSK(CEO Yoo-seok Hong) invigorates ‘Triumeq’ prescriptions.
According to GSK, ‘Triumeq(dolutegravir 50mg, abacavir 600mg, lamivudine 300mg),’ a complex HIV treatment which contains dolutegravir for the first time, has become a drug which can be prescribed for a number of HIV patients as going th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
